These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26107956)

  • 1. Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.
    Pfafferott K; Deshpande P; McKinnon E; Merani S; Lucas A; Heckerman D; Mallal S; John M; Gaudieri S; Lucas M
    PLoS One; 2015; 10(6):e0130420. PubMed ID: 26107956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of CD4
    Lucas M; Deshpande P; James I; Rauch A; Pfafferott K; Gaylard E; Merani S; Plauzolles A; Lucas A; McDonnell W; Kalams S; Pilkinton M; Chastain C; Barnett L; Prosser A; Mallal S; Fitzmaurice K; Drummer H; Ansari MA; Pedergnana V; Barnes E; John M; Kelleher D; Klenerman P; Gaudieri S
    Sci Rep; 2018 May; 8(1):7224. PubMed ID: 29740042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Transmitted Virus on the Host's Immune Response: A Case Study.
    Merani S; Lucas M; Deshpande P; Pfafferott K; Chopra A; Cooper D; Leary S; Luciani F; Gaudieri S
    Viral Immunol; 2017 Sep; 30(7):533-541. PubMed ID: 28530508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities.
    Lauer GM; Ouchi K; Chung RT; Nguyen TN; Day CL; Purkis DR; Reiser M; Kim AY; Lucas M; Klenerman P; Walker BD
    J Virol; 2002 Jun; 76(12):6104-13. PubMed ID: 12021343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
    Neveu B; Debeaupuis E; Echasserieau K; le Moullac-Vaidye B; Gassin M; Jegou L; Decalf J; Albert M; Ferry N; Gournay J; Houssaint E; Bonneville M; Saulquin X
    Hepatology; 2008 Sep; 48(3):713-22. PubMed ID: 18712791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
    Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
    Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
    Timm J; Li B; Daniels MG; Bhattacharya T; Reyor LL; Allgaier R; Kuntzen T; Fischer W; Nolan BE; Duncan J; Schulze zur Wiesch J; Kim AY; Frahm N; Brander C; Chung RT; Lauer GM; Korber BT; Allen TM
    Hepatology; 2007 Aug; 46(2):339-49. PubMed ID: 17559151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.
    Ziegler S; Ruhl M; Tenckhoff H; Wiese M; Heinemann FM; Horn PA; Spengler U; Neumann-Haefelin C; Nattermann J; Timm J;
    J Hepatol; 2013 Jan; 58(1):24-30. PubMed ID: 22925811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Neumann-Haefelin C; Timm J; Spangenberg HC; Wischniowski N; Nazarova N; Kersting N; Roggendorf M; Allen TM; Blum HE; Thimme R
    Hepatology; 2008 Jun; 47(6):1824-36. PubMed ID: 18454507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
    J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
    von Delft A; Humphreys IS; Brown A; Pfafferott K; Lucas M; Klenerman P; Lauer GM; Cox AL; Gaudieri S; Barnes E
    Gut; 2016 Jan; 65(1):112-23. PubMed ID: 26092843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degree of cross-genotype reactivity of hepatitis C virus-specific CD8+ T cells directed against NS3.
    Giugliano S; Oezkan F; Bedrejowski M; Kudla M; Reiser M; Viazov S; Scherbaum N; Roggendorf M; Timm J
    Hepatology; 2009 Sep; 50(3):707-16. PubMed ID: 19637188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure.
    Rauch A; James I; Pfafferott K; Nolan D; Klenerman P; Cheng W; Mollison L; McCaughan G; Shackel N; Jeffrey GP; Baker R; Freitas E; Humphreys I; Furrer H; Günthard HF; Hirschel B; Mallal S; John M; Lucas M; Barnes E; Gaudieri S
    Hepatology; 2009 Oct; 50(4):1017-29. PubMed ID: 19670417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential virus-specific CD8
    Luxenburger H; Graß F; Baermann J; Boettler T; Marget M; Emmerich F; Panning M; Thimme R; Nitschke K; Neumann-Haefelin C
    J Viral Hepat; 2018 Jul; 25(7):779-790. PubMed ID: 29397015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB
    J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.